Skip to main content

Table 1 Demographic and clinical characteristics of the study sample

From: Response inhibition alterations in migraine: evidence from event-related potentials and evoked oscillations

  MwoA (n = 22)
(M ± SEM)
Controls (n = 25)
(M ± SEM)
Group comparison
Age, years 30.86 ± 1.21 30.24 ± 0.70 t (45) = − 0.46, p > 0.05
Gender (F/M) (19/3) (18/7) χ2 = 2.40, p > 0.05
Education, years 15.55 ± 0.59 15.32 ± 0.45 t (45) = −0.31, p > 0.05
BMI [kg/m2] 21.09 ± 0.77 21.04 ± 0.52 t (45) = − 0.06, p > 0.05
SAS 44.43 ± 2.27 39.45 ± 1.49 t (45) = − 1.88, p > 0.05
SDS 44.67 ± 2.97 42.85 ± 2.13 t (45) = − 0.51, p > 0.05
Duration of migraine, hours 30.61 ± 5.47   
History of migraine, years 12.41 ± 1.34
Migraine frequency, times per month 5.00 ± 0.92
Severity of headache (VAS scale) 8.23 ± 0.25
  1. VAS visual analog scale, with 0 indicating no pain and 10 worst possible pain, SAS Self-Rating Anxiety Scale, SDS Self-Rating Depression Scale, BMI body mass index, M mean, SEM standard error of the mean